CORZQ — Core Scientific Balance Sheet
0.000.00%
- $536.57m
- $1.36bn
- $640.31m
- 18
- 30
- 89
- 43
Annual balance sheet for Core Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 6.66 | 8.67 | 118 | 15.9 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.177 | 1.11 | 1.68 | 0.257 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 11.1 | 70.9 | 757 | 85.1 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 81.3 | 85.2 | 597 | 712 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Other Long Term Assets | ||||
Total Assets | 162 | 226 | 2,439 | 808 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 19.5 | 69.6 | 320 | 187 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 26.2 | 91.9 | 1,053 | 1,217 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 136 | 134 | 1,386 | -409 |
Total Liabilities & Shareholders' Equity | 162 | 226 | 2,439 | 808 |
Total Common Shares Outstanding |